Skip to main content
Premium Trial:

Request an Annual Quote

Craig Mello

Premium

Invitrogen said this week that RNAi pioneer Craig Mello has joined the company as a scientific advisor in the area of RNAi research.

According to Invitrogen, Mello will assist in the development and implementation of RNAi strategies at the company.

Mello is currently a professor at the University of Massachusetts medical school and a Howard Hughes investigator. Mello holds a PhD from Harvard University and a bachelor’s degree in biochemistry from Brown University. He also recently joined the scientific advisory board of RNAi therapeutics developer CytRx.

“Our association with Dr. Mello opens doors to exciting new areas of discovery in RNAi,” Claude Benchimol, Invitrogen’s senior vice president of research and development, said in a statement. “By bringing his invaluable knowledge and experience in this area to our team, we hope to outpace the growing demand for cutting-edge methods to speed drug discovery research. We are honored to have him help with our development efforts.”

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.